eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2007
vol. 32
 
Share:
Share:
abstract:


Clinical immunology
Evaluation of the protease-antiprotease balance disorder in smoking and non-smoking patients treated for acute chronic obstructive pulmonary disease (COPD) at different clinical stages of the illness

Andrzej Kuźmiński
,
Zbigniew Bartuzi
,
Michał Przybyszewski
,
Magdalena Żbikowska-Gotz
,
Andrzej Dziedziczko
,
Małgorzata Graczyk

(Centr Eur J Immunol 2007; 32 (4): 212-215)
Online publish date: 2007/12/10
View full text Get citation
 
Introduction: The purpose of this paper is to present the level of protease-antiprotease balance disorder with patients hospitalised for acute COPD depending on the stage of the condition in relation to smokers and non-smokers.
Materials and Methods: The research was carried out on 61 patients with COPD. They consisted of 27 women and 34 men; 32 smokers and 30 non-smokers, age 18-82 (average 59.9±12 years). All patients underwent: measurement of concentrations: alfa-1-antiproteinase (α1-PI) and elastase (EN) (ELISA Immuno Diagnostic) in serum.
Results: A negative Spearman correlation between the concentration of elastase and the concentration of 1-antiprotease in the group of patients with severe and serious COPD and in the smokers’ group; respectively (r=–0.845 and p=0.001); (r=–0.529 and p=0.014) and (r=–0.506 and p=0.003). Statistically significant difference of elastase concentrations between the severe COPD group (by GOLD) and the remaining groups with p<0.05. Statistically significant difference of EN and α1-PI concentrations between the groups of smokers and non-smokers; with p<0.0001 and p=0.027.
Conclusions: Patients with COPD develop a severe protease-antiprotease balance disorder to the advantage of proteases. The balance disorder increases together with an increase in the level of COPD. Smoking increases the protease-antiprotease balance disorder and constitutes a significant risk factor for the intensification of irreversible obstructive changes within the respiratory system with patients with COPD. Giving up smoking causes a decrease in the adverse changes in the balance and is the most significant factor that improves the prognosis for patients with COPD.
keywords:

elastase, alfa-1-antiproteinase, COPD, protease-antiprotease balance

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.